Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News bluebird bio Inc BLUE

Healthcare Biotechnology
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new... see more

Recent & Breaking News (NDAQ:BLUE)

bluebird bio to Present at Two Upcoming Investor Conferences

Business Wire April 27, 2016

bluebird bio Reports Interim Clinical Data from Starbeam Study of Lenti-D(TM) at AAN 2016 Annual Meeting

Business Wire April 20, 2016

bluebird bio to Present Immuno-Oncology and Gene Therapy Data at the ASGCT 19th Annual Meeting

Business Wire April 18, 2016

bluebird bio to Present Clinical Data on Lenti-D in CALD in Plenary Session at AAN 2016 Annual Meeting

Business Wire March 3, 2016

bluebird bio to Present at Three Upcoming Investor Conferences

Business Wire March 2, 2016

bluebird bio Announces Transition of Chief Financial Officer

Business Wire February 25, 2016

bluebird bio Reports Fourth Quarter and Full Year 2015 Financial Results and Recent Operational Progress

Business Wire February 24, 2016

Bluebird Bio Gains 9% After Co. Begins New Phase 1 Study

Press Releases February 17, 2016

bluebird bio Reports First Patient Has Been Treated with bb2121 in CRB-401 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma

Press Releases February 17, 2016

bluebird bio Announces First Patient Treated with bb2121 in CRB-401 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma

Press Releases February 17, 2016

bluebird bio to Present at the 34th Annual J.P. Morgan Healthcare Conference

Business Wire January 5, 2016

Beyond the Chart, What Price Data Reveals - Research on Priceline Group, bluebird bio, Cheniere Energy and Biogen

Accesswire December 8, 2015

bluebird bio Presents Pre-Clinical and Manufacturing Data from CAR T Oncology Programs at ASH Annual Meeting

Business Wire December 6, 2015

bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 and HGB-206 Studies of LentiGlobin® at ASH Annual Meeting

Business Wire December 6, 2015

bluebird bio Reports New Beta-thalassemia Major Data from Northstar Study of LentiGlobin® at ASH Annual Meeting

Business Wire December 5, 2015

bluebird bio and ViroMed Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy

Business Wire December 3, 2015

bluebird bio Announces Participation in 27th Annual Piper Jaffray Healthcare Conference

Business Wire November 25, 2015

bluebird bio to present LentiGlobin® BB305 Clinical Data and bb2121 Preclinical Data at Annual Meeting of the American Society of Hematology

Business Wire November 5, 2015

bluebird bio Reports Third Quarter 2015 Financial Results and Recent Operational Progress

Business Wire November 4, 2015

bluebird bio Announces Participation in 24th Annual Credit Suisse Healthcare Conference

Business Wire November 4, 2015